Keyphrases
Tuberculosis
100%
Immunocompromised Patients
100%
Risk Assessment
100%
Tuberculin Skin Test
83%
HIV Infection
50%
HIV Patients
33%
Chronic Kidney Disease
33%
Solid Organ Transplant Recipients
33%
ELISPOT
33%
Control Subjects
33%
Rheumatoid Arthritis
33%
European Countries
16%
Interferon-gamma Release Assay
16%
Healthy Controls
16%
Clinical Trials
16%
Latent Infection
16%
QuantiFERON-TB Gold In-Tube
16%
Stem Cell Transplantation
16%
Preventive Chemotherapy
16%
Tuberculosis Incidence
16%
TB Screening
16%
Positive Check
16%
Solid Organ
16%
Active Tuberculosis
16%
In-tube
16%
Immunodeficiency
16%
Mycobacterium Tuberculosis (M. tb)
16%
Medicine and Dentistry
Immunocompromised Patient
100%
Mantoux Test
100%
Human Immunodeficiency Virus Infection
60%
Interferon Gamma Release Assay
60%
Inflammatory Arthritis
40%
Rheumatoid Arthritis
40%
Human immunodeficiency virus
40%
Chronic Kidney Disease
40%
Transplantation
40%
Enzyme Linked Immunosorbent Assay
40%
Interferon
20%
Stem Cell Therapy
20%
Release Assay
20%
QuantiFERON
20%
Enzyme Assay
20%
Stem Cell Transplant
20%
Neutron Capture Therapy
20%
Tuberculosis
20%
Clinical Trial
20%
Immune Deficiency
20%
Infection
20%
Mycobacterium Tuberculosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Immunocompromised Patient
100%
Tuberculin
100%
Human Immunodeficiency Virus Infection
60%
Inflammatory Arthritis
40%
Chronic Kidney Failure
40%
Rheumatoid Arthritis
40%
Enzyme-Linked Immunosorbent Assay
40%
HIV
40%
Mycobacterium Tuberculosis
20%
Immune Deficiency
20%
Interferon
20%
Infection
20%
Tuberculosis
20%
Clinical Trial
20%
Chemotherapy
20%